eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Allergy

Allergic Fungal Sinusitis: Workup

Author: John E McClay, MD, Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School
Coauthor(s): Bradley Marple, MD, Vice Chairman, Department of Otolaryngology, University of Texas Southwestern Medical Center
Contributor Information and Disclosures

Updated: Nov 17, 2009

Workup

Laboratory Studies

  • Total immunoglobulin E
    • Total IgE values generally are elevated in allergic fungal sinusitis (AFS), often to more than 1000 U/mL (normal values are <50 U/mL).
    • Total IgE level traditionally has been used to monitor the clinical activity of allergic bronchopulmonary fungal disease.
    • On the basis of similar IgE behavior associated with recurrence of allergic fungal sinusitis (AFS), total IgE levels have been proposed as a useful indicator of allergic fungal sinusitis (AFS) clinical activity.
  • Immunologic testing for allergens
    • RAST versus skin testing
      • Patients with allergic fungal sinusitis (AFS) generally demonstrate positive skin tests and in vitro (RAST) responses to fungal and nonfungal antigens. Manning et al, who compared 16 patients with histologically confirmed allergic fungal sinusitis (AFS) with a control group of patients with chronic rhinosinusitis, first demonstrated the sensitivity of RAST.Levels of fungal-specific IgE were uniformly elevated in all patients with allergic fungal sinusitis (AFS) and corresponded to the results of fungal cultures. In contrast, levels of fungal-specific IgE were not elevated within the control group. Moreover, patients with allergic fungal sinusitis (AFS) appear to demonstrate a broad sensitivity to a number of fungal and nonfungal antigens. Mabry et al have reported their experience, which indicates that patients with allergic fungal sinusitis (AFS) are allergic to multiple fungal antigens and to many typical nonfungal antigens.
      • Preliminary information suggests that methods of quantitative skin testing (in vivo) may provide even greater sensitivity ratings than RAST in patients with allergic fungal sinusitis (AFS). RAST traditionally has been considered less sensitive than skin testing during the investigation of atopy involving fungi. This has been attributed to technical problems, such as difficulty in binding the mold antigen to the carrier substrate.
      • To study the validity of this concept, Mabry et al prospectively evaluated 10 patients with allergic fungal sinusitis (AFS) for sensitivity to 11 pertinent fungi by both RAST and dilutional intradermal testing. A predictable correlation between RAST and skin test scores was observed in many, but not all, patients. Most often, this disparity was in the form of greater sensitivity indicated by skin testing than by RAST, sometimes differing by as many as 3 classes.
      • The lack of concordance was not confined to testing for fungi cultured from the sinuses, nor was it more or less pronounced in the case of dematiaceous fungi. The most likely causes for the disparity were thought to involve subtle differences in antigens used in skin test material as compared to RAST standards. Additionally, skin testing allowed observation of delayed and late-phase reactions, a measure not possible by specific IgE testing with RAST. This study appears to emphasize the importance of both skin testing and specific IgE testing via RAST in initial evaluation of patients in whom allergic fungal sinusitis (AFS) is suspected.
    • Nonspecific allergy testing
      • Gell and Coombs type I hypersensitivity in patients with allergic fungal sinusitis (AFS) can be demonstrated by elevation of serum total and fungal-specific IgE and by positive skin test results for fungal and nonfungal antigens. However, this reaction does not appear to be fungal specific.
      • Sensitivity to numerous fungi has been indicated both by in vitro (RAST) and in vivo methods (skin testing), although generally, only a single fungus is isolated by culture of corresponding allergic fungal mucin. This previously has been thought to represent either a common fungal epitope or a genetic predisposition toward fungal allergy in allergic fungal sinusitis (AFS).
      • Recent work by Chrzanowski et al identified the presence of an 18-kd protein in allergic mucin obtained from patients with allergic fungal sinusitis (AFS), which may represent such a pan-antigen.

Imaging Studies

  • Computed tomography
    • Accumulation of allergic fungal mucin eventually leads to the increasingly well-recognized radiographic findings characteristic of allergic fungal sinusitis (AFS). Heterogeneous areas of signal intensity within paranasal sinuses filled with allergic fungal mucin frequently are identified on CT scans (see Image 6, Image 8).
      • Although these findings are not specific for allergic fungal sinusitis (AFS), they remain relatively characteristic of the disease and may provide preoperative information supportive of a diagnosis of allergic fungal sinusitis (AFS). This characteristic, which is best identified using soft-tissue algorithms on CT scan, has been the focus of some interest.
      • An initial theory proposed that the role of hemosiderin occurring within inspissated mucin is responsible for the areas of increased signal intensity. This was disputed by Zinreich et al, who were unable to identify increased hemosiderin within typical allergic fungal mucin. Current evidence points to the presence of accumulations of heavy metals (eg, iron, manganese) and calcium salt precipitation within inspissated allergic fungal mucin as the most likely causes of these radiographic findings.11
    • Expansion, remodeling, or thinning of involved sinus walls is common in allergic fungal sinusitis (AFS) and is thought to be caused by the expansile nature of the accumulating mucin. Areas of high attenuation are found within the expanded paranasal sinuses in all patients. Similar radiographic findings can be caused by rare osteoid/chondroid matrix-producing sinonasal sarcomas or meningiomas.
    • Bony erosion of the sinus walls and extension into adjacent cavities have been mentioned in many reports, usually focusing on intracranial extension (see Image 6). In most series, a rate of approximately 20% bony erosion with extension into surrounding vital cavities is reported.
      • A recent review at UT Southwestern focusing on patterns of bony erosion in all the authors' patients found a 20% rate of erosion with extension. Sites of extension included the nasopharynx and pterygomaxillary space and intracranial and intraorbital areas.
      • A statistically significant association was identified between expansion of paranasal sinuses involved with disease and the presence of bone erosion.
      • The ethmoid sinus was the most commonly involved sinus, while the adjacent lamina papyracea was the most common bone to exhibit demineralization (see Image 8). Extension of allergic fungal sinusitis (AFS) beyond the confines of the paranasal sinuses most commonly occurred into the orbit, followed by the anterior, middle, and posterior cranial fossae, respectively.
      • When evaluating children and adults in the authors' population separately, no difference was observed in the amount or location of bony erosion with extension (see Table 3).
      • Despite the sometimes-remarkable extension into adjacent anatomic spaces, no cases of histologic invasion of fungus into the adjacent barriers of the orbital periosteum or dura of the brain were identified on histologic review.
    • Although bilateral in 51% of cases reviewed in a large interinstitutional trial of 45 patients, allergic fungal sinusitis (AFS) caused asymmetric involvement of the paranasal sinuses in 78% of patients. Asymmetrical involvement actually is more pronounced in children. In a review of 151 children and adults, the author and colleagues demonstrated that children have more asymmetrical involvement than adults (88% vs 58%) and have a much greater incidence of unilateral disease on presentation than adults (70% vs 37%). Adults in this study presented most often with bilateral disease, but as in the interinstitutional study, asymmetrical disease was seen more often.
    • Table 3. Sites of Extension of Allergic Fungal Sinusitis From the Paranasal Sinuses*

      Open table in new window

      [ CLOSE WINDOW ]
      Table
      SiteChildren (n=10) (25%, 10/40)Adults (n=23) (23%, 23/100)
      Intracranial anterior cranial fossa39
      Middle cranial fossa14
      Posterior cranial fossa22
      Orbit617
      Pterygopalatine fossa13
      Nasopharynx32
      SiteChildren (n=10) (25%, 10/40)Adults (n=23) (23%, 23/100)
      Intracranial anterior cranial fossa39
      Middle cranial fossa14
      Posterior cranial fossa22
      Orbit617
      Pterygopalatine fossa13
      Nasopharynx32
    • *Multiple sites were affected in some patients.
  • Magnetic resonance imaging  
    • MRI also can provide information useful in preoperative identification of allergic fungal mucin, but it usually is not necessary when making the diagnosis unless the disease has extended into the intracranial cavity or confusion exists with the diagnosis. Som and Curtin have pointed out that protein concentrations exceeding 28% cause a decreased signal on T1- and T2-weighted MRI images because of protein cross-linking and slower macromolecular motion. This effect is more pronounced on T2-weighted images because of prolonged magnetic field relaxation times. The high protein and low water concentration of allergic fungal mucin, coupled with the high water content within surrounding edematous paranasal sinus mucosa, gives rise to rather specific MRI characteristics (see Image 9).
    • In a series of 10 patients with allergic fungal sinusitis (AFS), Manning et al demonstrated that hypointense central T1 signal, central T2 signal void, and the presence of increased peripheral T1/T2 enhancement were highly specific for allergic fungal sinusitis (AFS) when compared to other forms of fungal sinusitis (invasive fungal sinusitis, fungal ball) and mucocele. On MRI, the hypointense signal looks black and can be mistaken for absence of disease in the paranasal sinuses because a black signal in the sinuses on CT scan indicates the absence of disease (compare Image 6 and Image 9). The combined CT scan and MRI findings provided a radiographic appearance that was highly specific for allergic fungal sinusitis (AFS).

Histologic Findings

Allergic fungal mucin (see Images 1-2) normally is first encountered at surgery. Therefore, recognition of its presence is the initial step in establishing an accurate diagnosis of allergic fungal sinusitis (AFS). Realizing that mucin, rather than paranasal sinus mucosa, demonstrates the histologic appearance consistent with allergic fungal sinusitis (AFS) is important. Examination of mucosa and polyps obtained from involved paranasal sinuses reveals findings consistent with the inflammation of a chronic inflammatory process and should be performed to exclude fungal invasion. Once mucin is collected, culture and pathologic examination are undertaken.

Initially described by Millar and Lamb and Katzenstein et al, histologic examination of allergic mucin reveals a constellation of characteristic findings.12 Branching noninvasive fungal hyphae are identified within sheets of eosinophils and elongated eosinophilic bodies (Charcot-Leyden crystals), which represent the product of eosinophilic degradation. Use of various histologic staining techniques helps to identify the variety of components within allergic fungal mucin. Hematoxylin and eosin (H&E) staining accentuates the mucin and cellular components of allergic fungal mucin. Using this stain, background mucin often takes on a chondroid appearance, while eosinophils and Charcot-Leyden crystals are heavily stained and become easily detectable.

Fungi fail to stain using this technique and therefore may be difficult to identify. The presence of fungi may be implicated on H&E stain by the resulting negative image against an otherwise stained background. However, fungal hyphae and elements are often rare, scattered, and fragmented within allergic mucin, rendering identification difficult unless specific histologic stains are used. Fungal elements are recognized for a unique ability to absorb silver. This property is the basis for various silver stains, such as the Grocott-Gomori methenamine silver (GMS) stain, which turns fungi black or dark brown. The use of a fungal stain complements the findings of initial H&E stain and is extremely important in the identification of fungi.

More on Allergic Fungal Sinusitis

Overview: Allergic Fungal Sinusitis
Workup: Allergic Fungal Sinusitis
Treatment: Allergic Fungal Sinusitis
Follow-up: Allergic Fungal Sinusitis
Multimedia: Allergic Fungal Sinusitis
References
Further Reading
[ CLOSE WINDOW ]

References

  1. Safirstein BH. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest. Dec 1976;70(6):788-90. [Medline].

  2. Robson JM, Hogan PG, Benn RA, et al. Allergic fungal sinusitis presenting as a paranasal sinus tumour. Aust N Z J Med. Aug 1989;19(4):351-3. [Medline].

  3. Loury MC, Leopold DA, Schaefer SD. Allergic Aspergillus sinusitis. Arch Otolaryngol Head Neck Surg. Sep 1993;119(9):1042-3. [Medline].

  4. Cody DT 2nd, Neel HB 3rd, Ferreiro JA, et al. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope. Sep 1994;104(9):1074-9. [Medline].

  5. Bent JP 3rd, Kuhn FA. Allergic fungal sinusitis/polyposis. Allergy Asthma Proc. Sep-Oct 1996;17(5):259-68. [Medline].

  6. Deshpande RB, Shukla A, Kirtane MV. Allergic fungal sinusitis: incidence and clinical and pathological features of seven cases. J Assoc Physicians India. Feb 1995;43(2):98-100. [Medline].

  7. McClay JE, Marple B, Kapadia L, et al. Clinical presentation of allergic fungal sinusitis in children. Laryngoscope. Mar 2002;112(3):565-9. [Medline].

  8. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope. Oct 1998;108(10):1485-96. [Medline].

  9. Feger TA, Rupp NT, Kuhn FA, et al. Local and systemic eosinophil activation in allergic fungal sinusitis. Ann Allergy Asthma Immunol. Sep 1997;79(3):221-5. [Medline].

  10. Marple BF, Gibbs SR, Newcomer MT, Mabry RL. Allergic fungal sinusitis-induced visual loss. Am J Rhinol. May-Jun 1999;13(3):191-5. [Medline].

  11. Zinreich SJ, Kennedy DW, Malat J, et al. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology. Nov 1988;169(2):439-44. [Medline].

  12. Millar J, Lamb D. Allergic bronchopulmonary aspergillosis of the maxillary sinuses. Thorax. 1981;36:710.

  13. Bent JP 3rd, Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope. Nov 1996;106(11):1331-4. [Medline].

  14. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol. Sep 1998;102(3):387-94. [Medline].

  15. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol. Sep 1998;102(3):395-402. [Medline].

  16. Denning DW, Van Wye JE, Lewiston NJ, et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest. Sep 1991;100(3):813-9. [Medline].

  17. Tsimikas S, Hollingsworth HM, Nash G. Aspergillus brain abscess complicating allergic Aspergillus sinusitis. J Allergy Clin Immunol. Aug 1994;94(2 Pt 1):264-7. [Medline].

  18. Kim JJ, Mazur LJ. Spectrum of noninfectious health effects from molds. Pediatrics. Dec 2006;118(6):2582-6. [Medline].

  19. Allphin AL, Strauss M, Abdul-Karim FW. Allergic fungal sinusitis: problems in diagnosis and treatment. Laryngoscope. Aug 1991;101(8):815-20. [Medline].

  20. Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. Nov 1994;111(5):580-8. [Medline].

  21. Berrettini S, Carabelli A, Papini M, et al. [Allergic fungal sinusitis: is this rare disease an allergy or infection?]. Acta Otorhinolaryngol Ital. Oct 1996;16(5):447-54. [Medline].

  22. Chrzanowski RR, Rupp NT, Kuhn FA, et al. Allergenic fungi in allergic fungal sinusitis. Ann Allergy Asthma Immunol. Nov 1997;79(5):431-5. [Medline].

  23. Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope. Jul 2004;114(7):1242-6. [Medline].

  24. Corey JP. Allergic fungal sinusitis. Otolaryngol Clin North Am. Feb 1992;25(1):225-30. [Medline].

  25. deShazo RD, O'Brien M, Chapin K, et al. Criteria for the diagnosis of sinus mycetoma. J Allergy Clin Immunol. Apr 1997;99(4):475-85. [Medline].

  26. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol. Jul 1995;96(1):24-35. [Medline].

  27. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. Jun 2004;12(3):237-42. [Medline].

  28. Ferguson BJ. Immunotherapy and antifungal therapy in allergic fungal sinusitis. Presented at: Annual Meeting of the American Academy. of Otolaryngic Allergy; Minneapolis, Minn. 1993.

  29. Ferguson BJ. What role do systemic corticosteroids, immunotherapy, and antifungal drugs play in the therapy of allergic fungal rhinosinusitis?. Arch Otolaryngol Head Neck Surg. Oct 1998;124(10):1174-8. [Medline].

  30. Folker RJ, Marple BF, Mabry RL, et al. Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope. Nov 1998;108(11 Pt 1):1623-7. [Medline].

  31. Gourley DS, Whisman BA, Jorgensen NL, et al. Allergic Bipolaris sinusitis: clinical and immunopathologic characteristics. J Allergy Clin Immunol. Mar 1990;85(3):583-91. [Medline].

  32. Graham SM, Carter KD. Response of visual loss in allergic fungal sinusitis to oral corticosteroids. Ann Otol Rhinol Laryngol. Mar 2005;114(3):247-9. [Medline].

  33. Greenberger P, Atkinson NF Jr, Yunginger JW, et al. Allergic bronchopulmonary aspergillosis. In: Middleton E, Reed C, Ellis E, et al, eds. Allergy Principles and Practice. St. Louis: Mosby; 1993:1395-1414.

  34. Gungor A, Adusumilli V, Corey JP. Fungal sinusitis: progression of disease in immunosuppression--a case report. Ear Nose Throat J. Mar 1998;77(3):207-10, 215. [Medline].

  35. Healy DY, Leid JG, Sanderson AR, et al. Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg. May 2008;138(5):641-7. [Medline].

  36. Jackson CG, Pappas DG Jr, Manolidis S, et al. Brain herniation into the middle ear and mastoid: concepts in diagnosis and surgical management. Am J Otol. Mar 1997;18(2):198-205; discussion 205-6. [Medline].

  37. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol. Jul 1983;72(1):89-93. [Medline].

  38. Katzenstein AL, Sale SR, Greenberger PA. Pathologic findings in allergic aspergillus sinusitis. A newly recognized form of sinusitis. Am J Surg Pathol. Jul 1983;7(5):439-43. [Medline].

  39. King HC, Mabry RL, Mabry CS. Allergy in ENT Practice. NY: Thieme Medical Publishers; 1998:227-42.

  40. Kinsella JB, Rassekh CH, Bradfield JL, et al. Allergic fungal sinusitis with cranial base erosion. Head Neck. May-Jun 1996;18(3):211-7. [Medline].

  41. Kuhn FA. Role of endoscopy in the management of chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. May 2004;193:15-8. [Medline].

  42. Kuhn FA, Swain R. Allergic fungal sinusitis: diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg. Feb 2003;11(1):1-5. [Medline].

  43. Kupferberg SB, Bent JP. Allergic fungal sinusitis in the pediatric population. Arch Otolaryngol Head Neck Surg. Dec 1996;122(12):1381-4. [Medline].

  44. Kupferberg SB, Bent JP 3rd, Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg. Jul 1997;117(1):35-41. [Medline].

  45. Lamb D, Millar J, Johnston A. Allergic aspergillosis of the paranasal sinuses. J Pathol. 1982;137:56.

  46. Liu JK, Schaefer SD, Moscatello AL, et al. Neurosurgical implications of allergic fungal sinusitis. J Neurosurg. May 2004;100(5):883-90. [Medline].

  47. Mabry RL, Mabry CS. Immunotherapy for allergic fungal sinusitis: the second year. Otolaryngol Head Neck Surg. Oct 1997;117(4):367-71. [Medline].

  48. Mabry RL, Manning S. Radioallergosorbent microscreen and total immunoglobulin E in allergic fungal sinusitis. Otolaryngol Head Neck Surg. Dec 1995;113(6):721-3. [Medline].

  49. Mabry RL, Manning SC, Mabry CS. Immunotherapy in the treatment of allergic fungal sinusitis. Otolaryngol Head Neck Surg. Jan 1997;116(1):31-5. [Medline].

  50. Mabry RL, Marple BF, Folker RJ, et al. Immunotherapy for allergic fungal sinusitis: three years' experience. Otolaryngol Head Neck Surg. Dec 1998;119(6):648-51. [Medline].

  51. Mabry RL, Marple BF, Mabry CS. Mold testing by RAST and skin test methods in patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg. Sep 1999;121(3):252-4. [Medline].

  52. Mabry RL, Marple BF, Mabry CS. Outcomes after discontinuing immunotherapy for allergic fungal sinusitis. Otolaryngol Head Neck Surg. Jan 2000;122(1):104-6. [Medline].

  53. Manning SC, Mabry RL, Schaefer SD, et al. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope. Jul 1993;103(7):717-21. [Medline].

  54. Manning SC, Merkel M, Kriesel K, et al. Computed tomography and magnetic resonance diagnosis of allergic fungal sinusitis. Laryngoscope. Feb 1997;107(2):170-6. [Medline].

  55. Manning SC, Vuitch F, Weinberg AG, et al. Allergic aspergillosis: a newly recognized form of sinusitis in the pediatric population. Laryngoscope. Jul 1989;99(7 Pt 1):681-5. [Medline].

  56. Marple BF. Allergic fungal rhinosinusitis: surgical management. Otolaryngol Clin North Am. Apr 2000;33(2):409-19. [Medline].

  57. Marple BF. Allergic fungal sinusitis. Current opinion in otolaryngology & head and neck surgery. 1999;7:383-387.

  58. Marple BF, Mabry RL. Allergic fungal sinusitis: learning from our failures. Am J Rhinol. Jul-Aug 2000;14(4):223-6. [Medline].

  59. Marple BF, Mabry RL. Comprehensive management of allergic fungal sinusitis. Am J Rhinol. Jul-Aug 1998;12(4):263-8. [Medline].

  60. McClay JE, Marple BF, Kapadia L, et al. Presented at: The American Society of. In: Clinical presentation of allergic fungal sinusitis in children. Orlando, Fla: Pediatric Otolaryngology; 2000.

  61. Medical Economics Staff. Physicians' Desk Reference. 53rd ed. 1999.

  62. Mirante JP, Krouse JH, Munier MA, et al. The role of powered instrumentation in the surgical treatment of allergic fungal sinusitis. Ear Nose Throat J. Aug 1998;77(8):678-80, 682. [Medline].

  63. Mukherji SK, Figueroa RE, Ginsberg LE, et al. Allergic fungal sinusitis: CT findings. Radiology. May 1998;207(2):417-22. [Medline].

  64. Nussenbaum B. Presented at: Southern Section of the American Laryngological, Rhinological, and Otological Society, Inc.; Abstract. St. Petersburg, Fla: 2000.

  65. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. Sep 1999;74(9):877-84. [Medline].

  66. Rains BM 3rd, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol. Jan-Feb 2003;17(1):1-8. [Medline].

  67. Ramadan HH, Quraishi HA. Allergic mucin sinusitis without fungus. Am J Rhinol. Mar-Apr 1997;11(2):145-7. [Medline].

  68. Revankar SG. Dematiaceous fungi. Mycoses. Mar 2007;50(2):91-101. [Medline].

  69. Schnadig VJ, Rassekh CH, Gourley WK. Allergic fungal sinusitis. A report of two cases with diagnosis by intraoperative aspiration cytology. Acta Cytol. Mar-Apr 1999;43(2):268-72. [Medline].

  70. Schubert MS. Allergic fungal sinusitis. Otolaryngol Clin North Am. Apr 2004;37(2):301-26. [Medline].

  71. Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs. 2004;64(4):363-74. [Medline].

  72. Sher TH, Schwartz HJ. Allergic Aspergillus sinusitis with concurrent allergic bronchopulmonary Aspergillus: report of a case. J Allergy Clin Immunol. May 1988;81(5 Pt 1):844-6. [Medline].

  73. Som PM, Curtin HD. Chronic inflammatory sinonasal diseases including fungal infections. The role of imaging. Radiol Clin North Am. Jan 1993;31(1):33-44. [Medline].

  74. Stonebraker AC, Schlosser RJ. Orbital volumetric analysis of allergic fungal sinusitis patients with proptosis before and after endoscopic sinus surgery. Am J Rhinol. May-Jun 2005;19(3):302-6. [Medline].

  75. Thakar A, Sarkar C, Dhiwakar M, et al. Allergic fungal sinusitis: expanding the clinicopathologic spectrum. Otolaryngol Head Neck Surg. Feb 2004;130(2):209-16. [Medline].

  76. Torres C, Ro JY, el-Naggar AK, et al. Allergic fungal sinusitis: a clinicopathologic study of 16 cases. Hum Pathol. Aug 1996;27(8):793-9. [Medline].

  77. Travis WD, Kwon-Chung KJ, Kleiner DE, et al. Unusual aspects of allergic bronchopulmonary fungal disease: report of two cases due to Curvularia organisms associated with allergic fungal sinusitis. Hum Pathol. Dec 1991;22(12):1240-8. [Medline].

  78. Wise SK, Ghegan MD, Gorham E, et al. Socioeconomic factors in the diagnosis of allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg. Jan 2008;138(1):38-42. [Medline].

  79. Wise SK, Venkatraman G, Wise JC, et al. Ethnic and gender differences in bone erosion in allergic fungal sinusitis. Am J Rhinol. Nov-Dec 2004;18(6):397-404. [Medline].

  80. Young CN, Swart JG, Ackermann D, et al. Nasal obstruction and bone erosion caused by Drechslera hawaiiensis. J Laryngol Otol. Feb 1978;92(2):137-43. [Medline].

[ CLOSE WINDOW ]

Further Reading

Clinical guidelines
Committee on Environmental Health, American Academy of Pediatrics, Kim JJ, Mazur LJ. Spectrum of noninfectious health effects from molds. Pediatrics 2006 Dec;118(6):2582-6. 18

[ CLOSE WINDOW ]

Keywords

sinusitis, fungal sinusitis, allergic fungal sinusitis, allergic Aspergillus sinusitis, allergic aspergillosis of paranasal sinuses, Aspergillus species, AFS, allergic mucin, allergic bronchopulmonary aspergillosis, ABPA, allergic fungal sinusitis, chronic rhinosinusitis, allergic rhinitis, chronic sinusitis, purulent rhinorrhea, sinusitis treatment, sinus infection, sinus problems, allergic sinusitis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

John E McClay, MD, Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School
John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Bradley Marple, MD, Vice Chairman, Department of Otolaryngology, University of Texas Southwestern Medical Center
Bradley Marple, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Rhinologic Society, Texas Medical Association, and Triological Society
Disclosure: Nothing to disclose.

Medical Editor

Lanny Garth Close, MD, Chair, Professor, Department of Otolaryngology-Head and Neck Surgery, Columbia University College of Physicians and Surgeons
Lanny Garth Close, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physicians, American Laryngological Association, American Society for Head and Neck Surgery, and New York Academy of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Stephen G Batuello, MD, Consulting Staff, Colorado ENT Specialists
Stephen G Batuello, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American Medical Association, and Colorado Medical Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.